Prognostic factors in 1,038 women with metastatic breast cancer. - Wikidata - awgldk - TriplyDB

Prognostic factors in 1,038 women with metastatic breast cancer.

Prognostic factors in 1,038 women with metastatic breast cancer.

http://www.wikidata.org/entity/Q37321930

about

A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer National consensus in China on diagnosis and treatment of patients with advanced breast cancer ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†The reaction of bone to tumor growth from human breast cancer cells in a rat spine single metastasis model.Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.Survival differences among women with de novo stage IV and relapsed breast cancer.Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial.Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study.Retrospective analysis of metastatic behaviour of breast cancer subtypes Defining the survival benchmark for breast cancer patients with systemic relapse An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US.SEOM clinical guidelines in metastatic breast cancer 2015.Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse.Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients Malignant pleural and pericardial effusions and meningeal infiltrates without other metastases in breast cancer: A case report.A Case Report of Local Recurrence Developing 24 Years After Mastectomy for Breast Cancer Recurrence From Breast Cancer After 24 Years Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis.Primary or metastatic hepatic carcinoma? A breast cancer patient after adjuvant chemotherapy and radiotherapy postoperatively with intrahepatic cholangiocarcinoma and review of the literature.Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013 Prognostic factors and survival in metastatic breast cancer: A single institution experience.Tight junctions: a barrier to the initiation and progression of breast cancer?Liver resections of isolated liver metastasis in breast cancer: results and possible prognostic factors.Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.Assessment of general characteristics of patients with primary metastatic breast carcinoma: single center experience.

P2860

Q26738942-2CB5C961-3250-4611-A3E6-51463EA2AD98 Q26775621-91EC66F5-353C-48B9-ABCD-476C7ABCA0C0 Q30317067-C3DDA900-BB73-45FC-A8E1-8B9FCC821044 Q30415248-3BDCA901-2A9B-403E-A9D1-1B2540EF9B20 Q33682910-9F20A5CF-620A-42EE-92C5-C402E519784B Q33709532-2C916A00-195F-4E08-9C58-A5F55BC1AEB0 Q33834401-3340DDFB-FD47-4A4F-8FED-56E42E548C82 Q33913545-BFA8FC14-4C4F-4879-86CF-DAF0A085A9CE Q34231099-835E1583-5321-4869-AF7A-AE1402E1BB67 Q34348721-5ECB3316-FAB6-425D-9153-DEC2D033782C Q35054455-C1554DBB-1897-4A5D-A854-53287C592891 Q35138699-521B49DC-A811-4E29-AB3E-3028CFAFF4A5 Q35252752-F38029C5-04AB-4D2A-90B0-E1BB2C44F480 Q35459288-01BFC1DA-057E-4290-A302-9F38B925527C Q35611844-871A7E7B-B7CF-4E39-BBD1-4284D4EC5125 Q35677925-328D2461-179C-4DEF-8459-F5661546DDA1 Q35683537-B42C752C-3D62-4E24-8A5C-B5D860B1B418 Q35829230-7CF421C6-C643-4830-970F-56B6F42808D5 Q35930745-07865644-AE6B-4C8A-A22C-D72B633C31E5 Q36069770-798D6E8F-95A9-4C7B-A967-D1EBE7A62508 Q36366093-B105259E-93AA-40FA-9810-C7C9C6E19384 Q36400360-4C37F91E-3A31-4B10-8B71-5F0AA2C2433A Q36441543-2F96E002-271A-4C74-B789-6346A74D6698 Q36448069-63AAF2A9-7807-461C-8D27-E192C60C77EF Q36482781-53509A5D-FB11-408A-AFAC-EC7CA731FC35 Q36545146-2B147E69-8B06-4A16-9FED-168A2D2022EA Q36672852-88675F6A-4123-4267-9B25-30C2D1AA5C73 Q36745487-E7F76447-A525-4234-A8DD-6943D703F502 Q36757904-85736B7A-45C3-465C-B794-17E7AEEE54A7 Q36824576-44ED11A3-BAAB-4245-B3DC-13B3D6479279 Q36988780-299C1259-DC43-4667-BDB2-8155B3A30949 Q37014479-AC7EFCA4-24BE-47BD-A471-227F9522D884 Q37031974-8A0B6F1E-A52D-4CF2-9D52-C9F7D7001083 Q37096940-548752D4-39FE-4937-8EAE-B12008BF1ECE Q37169342-65541193-7443-4EEC-A64B-D01792F53097 Q37392167-A95F3C79-DC0F-4B0B-AE8E-B7A31C936D57 Q37420725-6165071A-7E7C-4864-BBD4-5F6AE3B274F7 Q37556978-08C5244D-B87F-49EF-BD4A-DE32A13F8AEE Q37564518-BAA58413-F72C-4532-8C19-41427F6909C8 Q37601851-588E0345-9BE0-4CF6-B959-2F1F43EF9073

P2860

Prognostic factors in 1,038 women with metastatic breast cancer.

http://www.wikidata.org/entity/Q37321930

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic factors in 1,038 women with metastatic breast cancer.

@en

Prognostic factors in 1,038 women with metastatic breast cancer.

@nl

type

label

Prognostic factors in 1,038 women with metastatic breast cancer.

@en

Prognostic factors in 1,038 women with metastatic breast cancer.

@nl

prefLabel

Prognostic factors in 1,038 women with metastatic breast cancer.

@en

Prognostic factors in 1,038 women with metastatic breast cancer.

@nl

P1433

Q37321930-1A7A80A5-2C13-44EF-B273-FB00501DE8D4

P1476

Q37321930-BAF25F64-4E50-4BEE-97CE-C6D4FC1E77C2

P2093

Q37321930-0AF34971-A683-432D-9583-E8E875A90677

Q37321930-284964FC-F81F-4664-9978-B6F94C60D9BB

Q37321930-4AD99E40-64FA-4E7D-A26B-D6904831E379

Q37321930-6BC4C6B8-322D-4DF0-968C-A42FC36DB05C

Q37321930-79D9C832-764F-4CDE-9DD0-782A03630200

Q37321930-7A74CA57-2B52-4128-8864-CA931A99BDC5

Q37321930-7C2B9216-EE78-4DF9-93B5-D5BE9B84C266

Q37321930-963D07C3-15B7-4D05-9C34-1904E8BBF808

Q37321930-A53E60CD-7C3B-43F1-90F2-C9082E972BA2

Q37321930-AC0E40CA-3ADF-4B43-A270-1CA89FDBEAD0

P2860

Q37321930-0B02BC77-BAFA-4663-A300-A31D026A1E02

Q37321930-127AFE3D-B718-472D-8F9F-6F09ACD9024E

Q37321930-345FD4D5-DA84-40F7-BDB9-FCD97D6FEE9F

Q37321930-37706362-5C19-4C87-8AE6-1E68049A8F7E

Q37321930-3A8CBE45-3CB2-4AE3-BF8D-3B4BCD542B32

Q37321930-5C39667B-2500-4A62-9D6B-8D568237B3D5

Q37321930-6913755F-011E-4741-B24F-7CC8AAFEA0F4

Q37321930-82F6D7B7-E279-40F9-9789-F2077BAD70B8

Q37321930-8E89FC3B-6DA9-4360-9E7E-1CAE32E4C689

Q37321930-94993043-4427-461F-881E-4F1C33DAF184

P304

Q37321930-BF1CA27F-B5D5-4E5F-9707-9A2F866BBE53

P31

Q37321930-C8894D53-A86E-4103-AD40-76C9B0F0F8A2

P356

Q37321930-8A645CF5-45F4-4D73-AC46-D3ADCFAD2E59

P433

Q37321930-02141E4E-DCCB-4FCA-ABF6-F44EF2301CBF

P478

Q37321930-D44EC83C-8E3B-4B38-8517-7EB490AC7131

P577

Q37321930-AB2F161D-85BF-4E99-B65F-709346117521

P5875

Q37321930-10741028-4AC9-4AF1-8823-F60F90786D26

P698

Q37321930-50AEDA6D-39E4-4172-990D-6F986B92C23F

P932

Q37321930-6C3C1180-80A6-4AD1-8C3F-7D6889FD9080

P356

P1433

Annals of Oncology

P1476

Prognostic factors in 1,038 women with metastatic breast cancer.

@en

P2093

A Courdi

http://www.w3.org/2001/XMLSchema#string

C Balu-Maestro

http://www.w3.org/2001/XMLSchema#string

E Chamorey

http://www.w3.org/2001/XMLSchema#string

F Ettore

http://www.w3.org/2001/XMLSchema#string

I Birtwisle-Peyrottes

http://www.w3.org/2001/XMLSchema#string

I Raoust

http://www.w3.org/2001/XMLSchema#string

J Barriere

http://www.w3.org/2001/XMLSchema#string

J Doyen

http://www.w3.org/2001/XMLSchema#string

J M Hannoun-Levi

http://www.w3.org/2001/XMLSchema#string

J-M Ferrero

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.

Clinical course and prognostic factors following bone recurrence from breast cancer.

Survival, quality of life and breast cancer.

Simultaneous micro measurement of steroid receptors in breast cancer.

Survival after first recurrence of breast cancer. The Miami experience.

Second consensus on medical treatment of metastatic breast cancer.

Metastatic breast cancer: an updating.

Revision of the American Joint Committee on Cancer staging system for breast cancer.

P304

2012-2019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDN424

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51415110

http://www.w3.org/2001/XMLSchema#string

P698

18641006

http://www.w3.org/2001/XMLSchema#string

P932

2733115

http://www.w3.org/2001/XMLSchema#string